Concepedia

Tom Seijkens

TS

Statistics

Publications

33

Citations

2.6K

H-Index

24

Active since

2010

Affiliations

Ludwig-Maximilians-Universität München(Current)

University of Amsterdam

Maastricht University

Amsterdam University Medical Centers

Amsterdam UMC Location University of Amsterdam

Tom Seijkens is an author at Ludwig-Maximilians-Universität München specializing in inflammation, immunology, and life sciences.

ORCID

Publications per year

2010–2024

33

Publications

33

Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis

Dirk Lievens, Alma Zernecke, Tom Seijkens et al. · Blood · 2010 · 296 citations · Full text

, , +14

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

Esther Lutgens, Dirk Lievens, Linda Beckers et al. · The Journal of Experimental Medicine · 2010 · 245 citations · Full text

, , +17

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis

Tom Seijkens, Claudia M. van Tiel, Pascal Kusters et al. · Journal of the American College of Cardiology · 2018 · 194 citations · Full text

, , +16

Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions

Marten A. Hoeksema, Marion J. Gijbels, Jan Van den Bossche et al. · EMBO Molecular Medicine · 2014 · 179 citations · Full text

, , +14

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis

Kikkie Poels, Mandy M. T. van Leent, C. Boutros et al. · JACC CardioOncology · 2020 · 142 citations · Full text

, , +17

1–5 of 33